PFKFB4 is associated with resistance to sunitinib drugs in ccRCC by mediating the pentose phosphate pathway, which affects patient treatment and prognosis to a large extent [14]. This evidence concerns the gene PFKFB4 and nonpapillary renal cell carcinoma.